Home ARS Pharmaceuticals

ARS Pharmaceuticals

In operation
Series D
Developer of Epinephrine Nasal Spray

Basic Information

ARS Pharmaceuticals' mission is to provide better protection for high-risk patients and their families against severe allergic reactions. The company is developing ARS-1, a novel intranasal epinephrine spray that utilizes unique absorption technology. It is easy to use, convenient, and more reliable, designed for patients and loved ones at risk of life-threatening allergic reactions triggered by food, medication, or insect stings.
ARS Pharmaceuticals, Inc.
SanDiego,California,United States of America
less than 15 people
January 01, 2015
858-335-1300